patent/WO-2014006569-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
filingDate	2013-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13431134934c4bf77f2ae3215775d881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23f10ef801b4a5572fe367cdb6703f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e41abd40a7efee19c2f026f46996aefa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a44c3bbc98f03f592cf671c37d5d573a
publicationDate	2014-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-2014006569-A3
titleOfInvention	Saxagliptin salts
abstract	The present invention provides saxagliptin bisulphate, saxagliptin acetate, saxagliptin oxalate, saxagliptin bicarbonate, and saxagliptin carbonate, their polymorphic forms, processes for their preparation, and pharmaceutical compositions thereof.
priorityDate	2012-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6395767-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102086172-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012017029-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943656-B2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407286 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11243969

Total number of triples: 23.